Related Experiment Video

Updated: Aug 24, 2026

Minimally Invasive Murine Laryngoscopy for Close-Up Imaging of Laryngeal Motion During Breathing and Swallowing
07:45

Minimally Invasive Murine Laryngoscopy for Close-Up Imaging of Laryngeal Motion During Breathing and Swallowing

Published on: December 1, 2023

Pediatric myasthenia gravis and velopharyngeal incompetence

Anthony A Rieder1, Stephen F Conley, Laura Rowe

  • 1Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI, USA.

International Journal of Pediatric Otorhinolaryngology
|May 6, 2004
PubMed

Insights

Children with myasthenia gravis (MG) may develop velopharyngeal incompetence (VPI), impacting speech. Early diagnosis and long-term follow-up are crucial, with speech prostheses often needed for intervention.

Area of Science:

  • Pediatric Neurology
  • Speech Pathology
  • Genetics

Background:

  • Velopharyngeal incompetence (VPI) is a condition affecting speech production.
  • Myasthenia gravis (MG) is a neuromuscular disorder with variable presentations in children.

Purpose of the Study:

  • To investigate the clinical course of velopharyngeal incompetence in pediatric patients diagnosed with myasthenia gravis.
  • To identify diagnostic and management strategies for VPI associated with MG in children.

Main Methods:

  • Retrospective review of medical records from 538 children with VPI.
  • Identification and detailed analysis of cases with co-occurring myasthenia gravis.

Main Results:

  • Four pediatric cases of velopharyngeal incompetence associated with myasthenia gravis were identified.
  • All affected children required intervention to improve speech intelligibility.
  • Speech prostheses were the consistent intervention used across all identified cases.

Conclusions:

  • Neonatal myasthenia gravis patients require long-term monitoring for potential recurrence of speech impairment.
  • A high index of suspicion is necessary for early diagnosis of VPI in children with MG due to variable presentations.
  • Prompt diagnosis and intervention, such as speech prostheses, are vital for managing VPI in pediatric myasthenia gravis.
Abstract

More Related Videos

Isolation and Characterization of Satellite Cells from Rat Head Branchiomeric Muscles07:37

Isolation and Characterization of Satellite Cells from Rat Head Branchiomeric Muscles

Published on: July 20, 2015

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...